News
USFDA classifies Sun Pharma's Baska facility inspection as Official Action Indicated
18-Dec-2025 | 09:19
Sun Pharmaceutical Industries announced that the US FDA conducted an inspection at the Company's Baska facility from 8 September 2025 to 19 September 2025. The US FDA has subsequently determined that the inspection classification status of this facility is Official Action Indicated (OAI).
Powered by Capital Market - Live News
